Palani Kumaresan: Roche Diagnostics Is Ramping Up—Should Illumina Be Worried?

Roche’s AXELIOS sequencer, Alzheimer’s blood test, and push to automate mass spectrometry point to a broader strategy of making advanced diagnostics routine. Whether AXELIOS can meaningfully challenge Illumina’s sequencing dominance, however, remains an open question.

Hosted on Acast. See acast.com/privacy for more information.